Tianyin Receives GMP Certification From SFDA

Tianyin Pharmaceutical (Tianyin) has received the Good Manufacturing Practices Certificate for pharmaceutical products (GMP Certificate) from the State Food and Drug Administration (SFDA) in China.

Reportedly, based on the review of management practices of Tianyin’s new production facility, including quality control of raw materials, manufacturing processes, and the inspection and acceptance of its finished products it has been awarded the GMP Certificate.

Jiang, chairman and CEO of Tianyin, said: “We are very pleased with the SFDA’s decision to grant us the GMP certification, which is the result of hard work and dedication from our entire team. This certification is the final step to commencing production at our new facility and effectively tripling the capacity of our solid dosage medicines, such as Azithromycin Dispersible Tablets, Mycophenolate Mofetil Capsules, Dantong Capsules and other recently approved medicines in our portfolio. This will enable us to meet our projected 40% revenue growth for fiscal 2010 while providing the capacity to accommodate up to $100m in annual revenues as we look toward the future.”